borderline significanceP =0.09
Compared with patients with relatively stable eGFR Cr+CysC (Q3), those with decreased eGFR Cr+CysC (Q1) exhibited significantly increased adjusted risk of death (hazard ratio [HR], 1.96 [95% CI, 1.27–3.04], P =0.003) and those with increased eGFR Cr+CysC (Q5) exhibited borderline significance (HR, 1.51 [95% CI, 0.94–2.42], P =0.09), after adjusting for confounders, including baseline eGFR Cr+CysC and albumin‐to‐creatinine ratio.